Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1 2 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Completed 10 Unknown 5 Active not recruiting 3 Not yet recruiting 2 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pneumonia 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1

Interventions

icotinib 1 abarelix 1 Surgical Procedures, Operative 1 Prednisone 1 Oxycodone 1 Oxaliplatin 1 Morphine 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Fentanyl 1 Erlotinib Hydrochloride 1 Congresses as Topic 1 Clinical Protocols 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Suspended × Prednisone × Clear all

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡